Atlas Financial (AFH) Earning Positive Media Coverage, Analysis Shows

Share on StockTwits

Press coverage about Atlas Financial (NASDAQ:AFH) has trended positive recently, according to Accern. The research group ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Atlas Financial earned a coverage optimism score of 0.29 on Accern’s scale. Accern also gave news coverage about the insurance provider an impact score of 47.0420144355914 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

These are some of the news articles that may have effected Accern Sentiment Analysis’s scoring:

Shares of Atlas Financial traded down $0.65, reaching $10.35, during mid-day trading on Friday, according to Marketbeat.com. The company’s stock had a trading volume of 100,422 shares, compared to its average volume of 66,832. Atlas Financial has a 12-month low of $8.05 and a 12-month high of $21.50. The company has a market cap of $131.31 million, a P/E ratio of -2.86 and a beta of 1.11. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.55 and a current ratio of 0.56.

Atlas Financial (NASDAQ:AFH) last released its quarterly earnings data on Monday, August 6th. The insurance provider reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.44 by $0.03. Atlas Financial had a negative return on equity of 43.63% and a negative net margin of 16.52%. The business had revenue of $56.73 million for the quarter, compared to the consensus estimate of $57.30 million. analysts predict that Atlas Financial will post 1.7 earnings per share for the current fiscal year.

AFH has been the subject of a number of analyst reports. ValuEngine lowered shares of Atlas Financial from a “hold” rating to a “sell” rating in a research report on Sunday, July 8th. Zacks Investment Research lowered Atlas Financial from a “buy” rating to a “hold” rating in a research note on Thursday, May 3rd. Finally, Boenning Scattergood raised Atlas Financial from a “neutral” rating to an “outperform” rating and set a $10.00 target price on the stock in a research note on Tuesday, August 7th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $15.33.

In other news, Director John Taylor Maloney Fitzgerald purchased 6,000 shares of the company’s stock in a transaction that occurred on Thursday, June 28th. The shares were purchased at an average price of $8.90 per share, for a total transaction of $53,400.00. Following the purchase, the director now directly owns 50,354 shares of the company’s stock, valued at approximately $448,150.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 15.10% of the company’s stock.

Atlas Financial Company Profile

Atlas Financial Holdings, Inc, through its subsidiaries, engages in underwriting commercial automobile insurance policies in the United States. Its automobile insurance products provide insurance coverage in three primary areas, including liability, accident benefits, and physical damage. The company focuses on the light commercial automobile sector, including taxi cabs, non-emergency para-transit, limousine, livery, and business autos.

Read More: How to Invest in Growth Stocks

Insider Buying and Selling by Quarter for Atlas Financial (NASDAQ:AFH)

Receive News & Ratings for Atlas Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlas Financial and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Recent Analysts’ Ratings Updates for Hellofresh
Recent Analysts’ Ratings Updates for Hellofresh
Fabrinet  Stock Rating Lowered by Needham & Company LLC
Fabrinet Stock Rating Lowered by Needham & Company LLC
Avanos Medical  Lifted to Outperform at Raymond James
Avanos Medical Lifted to Outperform at Raymond James
ASLAN PHARMACEUTICALS ADR REP 5’s  “Buy” Rating Reaffirmed at HC Wainwright
ASLAN PHARMACEUTICALS ADR REP 5’s “Buy” Rating Reaffirmed at HC Wainwright
Phore Hits Market Capitalization of $8.38 Million
Phore Hits Market Capitalization of $8.38 Million
Reviewing Timberland Bancorp  & First Connecticut Bancorp
Reviewing Timberland Bancorp & First Connecticut Bancorp


Leave a Reply

© 2006-2018 Ticker Report. Google+.